Navigation Links
One third of stunting and a quarter of deaths among under 3s in poor countries could be prevented
Date:1/16/2008

If existing maternal and child nutrition interventions were implemented in poor countries, cases of stunting among under 3s could be reduced by a third, and deaths by up to a quarter, according to new research being published today.

Professor Simon Cousens, of the London School of Hygiene & Tropical Medicine, is one of the authors of a paper which appears as part of the Lancet Maternal and Child Undernutrition Series, which is being launched this week. Professor Cousens, along with four other series authors, is presenting his findings at a press event at the Science Media Centre.

178 million children under five are stunted, and most of these live in Sub-Saharan Africa and south-central Asia. 160 million stunted children (90%) live in just 36 countries, and make up 46% of the 348 million children in those countries. In addition, 19 million children are affected by severe acute malnutrition.

Historical evidence of improvements in nutrition in developed countries has shown that stature, living standards, reduced disease exposure and education are linked, and that almost all stunting is avoidable. Stunting is difficult to reverse after the age of three, so it is important to focus on interventions in pregnancy and in young children, especially those aged under two. In the past most nutrition programme reports and assessments have focused on weight gain rather than linear growth, and linear-growth retardation has been viewed as difficult to change. However, in the short term, about one third of stunting could be averted with existing interventions, say the authors. These include strategies to promote improved complementary feeding, micronutrient interventions, and interventions aimed at reducing the burden of disease.

In addition to reducing stunting, nutrition interventions, including breastfeeding promotion, could prevent about one quarter of child deaths in the 36 countries in which 90% of the worlds stunted children live, while universal supplementation with calcium, iron and folic acid of women during pregnancy could prevent around 100,000 maternal deaths (24% of the total) and 3.12 million DALYs.

Professor Cousens comments: Much can be done now to improve the nutritional status of mothers and children with simple, evidence-based interventions. Although there are intergenerational effects of undernutrition which will take many years to eliminate, promotion of breastfeeding, improved complementary feeding practices, interventions to improve micronutrient status and interventions to reduce the burden of child disease can all have an immediate impact on child nutrition. Attention to the continuum of maternal and child undernutrition is essential to attainment of several of the Millennium Development Goals and must be prioritised globally and within countries. Countries with a high prevalence of undernutrition must decide which interventions should be given the highest priority, and ensure their effective implementation at high coverage to achieve the greatest benefit.


'/>"/>

Contact: Gemma Howe
gemma.howe@lshtm.ac.uk
020-792-72802
London School of Hygiene & Tropical Medicine
Source:Eurekalert

Related medicine news :

1. STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call
2. American Life League Announces Third Training and Activism Weekend
3. ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding
4. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Third Quarter Earnings
5. The Ensign Group, Inc. Reports Third Quarter 2007 Earnings
6. Par Pharmaceutical Reports Third-Quarter 2007 Results
7. AHIP Releases Individual Market Guarantee Access Proposal, Announces Support for Third Party Review of Rescission Decisions
8. China Sky One Medical Completes Previously Announced Amendments to Form 10QSB for the Second and Third Quarters of 2006
9. AIRLIFE Denver Spreads its Wings with Third Helicopter
10. Surgical Care Affiliates Announces Investor Conference Call to Discuss Third Quarter 2007 Results
11. The Ensign Group, Inc. to Announce Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... Valencia, Calif. (PRWEB) , ... July 19, 2017 , ... ... has acquired the Minnesota based Health IT business unit of Constellation Inc., a move ... an already established base of operations in St. Louis, the acquisition is expected to ...
(Date:7/20/2017)... California (PRWEB) , ... July 19, 2017 , ... A ... that most successful weight loss surgery patients who had received a body contouring procedure ... health and beauty clinic Beverly Hills Physicians (BHP), which provides both types of procedures, ...
(Date:7/20/2017)... ... ... “Lucky the Buffalo and Her Adventures”: a collection of heartwarming children’s stories. “Lucky the ... Bieniek Jr. was born in Toledo, Ohio. He attended Woodward High School. He ... married to a brilliant woman with a caring heart named Tiina, who is a hospice ...
(Date:7/18/2017)... ... July 18, 2017 , ... ClinicalTrials.gov and the ... You Need to Consider?, **An FDAnews Webinar**, Aug. 2, 2017 — 1:30 p.m. ... “Final Rule for Clinical Trials Registration and Results Information,” is a head-scratcher. After ...
(Date:7/18/2017)... ... July 18, 2017 , ... An inventor from Anacortes, ... "Due to menopause, I have frequent hot flashes, and I suffer from anxiety and ... way to keep cool while out and about." INSTA-FAN meets that need. , This ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Corp., also known as ,The Epigenetics Company, announced today the release of ... using the myDNAge ™ test. Based on Horvath,s Clock, so named ... biostatistics at the David Geffen School of Medicine at UCLA ... ™ technology is used to analyze DNA methylation patterns of over ... Epigenetic ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
(Date:7/10/2017)... TRIANGLE PARK, N.C. , July 10, 2017 /PRNewswire/ ... a $5m Convertible Note to support the development of ... by Tencent Holdings Limited, a leading Chinese Internet services ... This funding will advance multiple infectious disease product programs ... Founded by Dr. ...
Breaking Medicine Technology: